- ISIN
- US75340L1044
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Jul 15, 2021
Highlights
- Market Cap
- $96.54M
- Enterprise Value
- $107.75M
- EPS (TTM)
- -$1.12
- Total Revenue (TTM)
- $34.38M
- Gross Profit (TTM)
- $5.80M
- EBITDA (TTM)
- -$47.18M
- Year Range
- $1.66 - $4.94
- Target Price
- $8.00
- ROA (TTM)
- -80.39%
- ROE (TTM)
- -245.79%
- Avg. Volume (1M)
- 217K
- Avg. Volume Value (1M)
- $434.14K
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
RPID Performance Chart
Rapid Micro Biosystems Inc (RPID) is down 26.6% since the beginning of the year. At $2 per share, RPID is trading 56.9% below its 52-week high of $5. Investors who bought $1,000 worth of RPID shares 5 years ago would now be looking at an investment worth $96.
Loading charts...
Compare this symbol against anything
Returns By Period
Rapid Micro Biosystems Inc (RPID) has returned -26.55% so far this year and -35.65% over the past 12 months.
Rapid Micro Biosystems Inc
- 1D
- 0.95%
- 1M
- 23.84%
- 6M
- -51.92%
- YTD
- -26.55%
- 1Y
- -35.65%
- 3Y*
- 29.98%
- 5Y*
- -37.42%
- 10Y*
- —
- ALL TIME*
- -37.34%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
RPID Monthly Returns History
Based on dividend-adjusted daily data since Jul 15, 2021, RPID's average daily return is -0.04%, while the average monthly return is -0.52%.
Historically, 38% of months were positive and 62% were negative. The best month was Jan 2025 with a return of +98.9%, while the worst month was Mar 2026 at -47.6%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 8 months.
On a daily basis, RPID closed higher 45% of trading days. The best single day was Jun 30, 2022 with a return of +35.2%, while the worst single day was Mar 12, 2026 at -21.8%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 52.76% | -2.26% | -47.58% | 5.73% | -16.25% | -13.93% | 23.12% | -26.55% | |||||
| 2025 | 98.89% | 70.39% | -13.44% | -12.12% | 43.53% | 3.60% | -3.48% | -27.63% | 38.59% | -10.48% | 40.13% | -30.79% | 222.22% |
| 2024 | 29.08% | 15.16% | -11.82% | 1.44% | -18.70% | -17.50% | 0.15% | 28.58% | 4.72% | 21.35% | -3.24% | -13.88% | 21.62% |
| 2023 | 32.74% | -28.67% | 22.43% | -24.05% | 5.53% | -4.76% | -1.87% | -1.66% | 11.92% | -4.63% | 13.59% | -36.75% | -34.51% |
| 2022 | -32.99% | -1.96% | -2.86% | -14.14% | -14.07% | -14.17% | 6.28% | -27.13% | -3.00% | -9.60% | -29.79% | -44.88% | -89.38% |
| 2021 | -1.38% | -14.83% | -2.28% | 10.40% | -39.58% | -13.64% | -52.71% |
Benchmark Metrics
Rapid Micro Biosystems Inc has an annualized alpha of -22.34%, beta of 1.27, and R2 of 0.06 versus S&P 500 Index. Calculated based on daily prices since July 15, 2021.
- This stock participated in 223.86% of S&P 500 Index downside but only 50.12% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.06 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -22.34%
- Beta
- 1.27
- R²
- 0.06
- Upside Capture
- 50.12%
- Downside Capture
- 223.86%
Return for Risk
Risk / Return Rank
RPID ranks 26 for risk / return — above 26% of stocks peers on PortfoliosLab. Its historical combined result is below the peer median.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Rapid Micro Biosystems Inc (RPID) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RPID | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.84 | ||
| Sortino ratioReturn per unit of downside risk | -2.13 | ||
| Omega ratioGain probability vs. loss probability | 0.98 | 1.25 | -0.27 |
| Calmar ratioReturn relative to maximum drawdown | -0.56 | 2.00 | -2.56 |
| Martin ratioReturn relative to average drawdown | -0.98 | 8.49 | -9.47 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Rapid Micro Biosystems Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Rapid Micro Biosystems Inc was 97.57%, occurring on Jul 3, 2024. The portfolio has not yet recovered.
The current Rapid Micro Biosystems Inc drawdown is 91.41%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-97.57%Jul 2024 | 2y 11mo | — | 4y 12moAug 2021 - now | — |
-17.01%Jul 2021 | 1d | 14d | 15dJul 2021 - Aug 2021 | — |
-4.89%Jul 2021 | 1d | 1d | 1dJul 2021 - Jul 2021 | — |
Drawdown Indicators
| RPID | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.57% | -56.78% | -40.79% |
Max Drawdown (1Y)Largest decline over 1 year | -64.53% | -9.10% | -55.43% |
Max Drawdown (3Y)Largest decline over 3 years | -64.53% | -18.90% | -45.63% |
Max Drawdown (5Y)Largest decline over 5 years | -97.57% | -25.43% | -72.14% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -91.41% | -1.58% | -89.83% |
Average DrawdownAverage peak-to-trough decline | -84.32% | -10.70% | -73.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 36.90% | 2.14% | +34.76% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Rapid Micro Biosystems Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Rapid Micro Biosystems Inc is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for RPID relative to other companies in the Medical Devices industry. Currently, RPID has a P/S ratio of 2.8. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for RPID in comparison with other companies in the Medical Devices industry. Currently, RPID has a P/B value of 4.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with RPID
Add Rapid Micro Biosystems Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with RPID